Key result
Catheter ablation, primarily through pulmonary vein isolation, achieves an approximate 75-80% non-recurrence rate at 12 months for paroxysmal atrial fibrillation and serves as a highly effective rhythm control strategy.
Catheter ablation is now a major, effective, and safe option for rhythm control in atrial fibrillation, replacing the historical reliance solely on antiarrhythmic drugs.
Supports ablation efficacy for paroxysmal AF; leaves open long-term durability versus contemporary therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shinsuke Miyazaki (2019) conducted a review in Atrial Fibrillation. Catheter Ablation vs. Antiarrhythmic drugs was evaluated. Catheter ablation, primarily through pulmonary vein isolation, achieves an approximate 75-80% non-recurrence rate at 12 months for paroxysmal atrial fibrillation and serves as a highly effective rhythm control strategy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: